University of Ioannina
Μοριακή μελέτη της γενετικής αστάθειας μικροδορυφορικού DNA σε καρκίνο μαστού: συσχέτιση με την ανοσοϊστοχημική έκφραση και τις μεταλλάξεις του p53
Abstract
dc:descriptionIntroduction-Purpose: It is now well accepted that genetic abnormalities, mainly mutations of oncogenes, onco-suppressor genes and repair genes, are crucial for cancer development and progression. The main goal of this study is to investigate the potential role of two biological parameters, microsatellite instability and p53 onco-suppressor gene mutations and expression, in breast cancer. Microsatellites are short tandem repeat DNA sequences, comprising multiple copies of a repeat unit of 1-13 base pairs. They are common, highly polymorphic and distributed widely throughout the genome. Recently, instability of these repeats (i.e. variations in the number of repetitive unit sequences) has been reported in a variety of cancers, but not in adjacent normal tissues from the same individual. It is also assumed that loss of DNA mismatch repair enzymes (MMR) may be involved. In this study, we investigated if there is evidence of Microsatellite Instability (MSI) or/and MMR deficiency in cancerous and adjacent normal breast tissues, with a set of 4 microsatellite markers. Alterations of the p53 tumor suppressor gene are probably the most common genetic abnormalities in human malignancies, including breast cancer. The majority of p53 mutations occur in the conserved DNA-binding domain (exons 5-8) and may lead to loss of DNA binding that is believed to be critical for the biological activity of p53. In breast cancer, frequency of p53 mutation is reported about 20%, lower than in other solid tumors. The implications for breast carcinogenesis however are unclear; in several studies it has been associated with more aggressive disease and worse overall survival. In our study we aimed to detect the presence of gene mutations in exons 5-8 and protein accumulation of p53 tumor-suppressor gene in breast carcinomas. Methods: DNA was extracted from 60 breast carcinomas of various histopathology and corresponding adjacent normal tissues. We investigated 4 highly informative and polymorphic microsatellite loci (D17S807, D16S301 D16S305 and GH) on chromosomes 17, 16q22.1, 16q24.3 and 17q22-24 respectively, with radiolabeled PCR and autoradiography. We also studied immunohistochemical expression of MMR proteins MSH2 and MLH1. In the second phase, we used a PCR and GC-clamped DGGE assay, followed by sequencing, to investigate the presence of mutations within exons 5-8 of p53 gene. Additionally, we looked for p53 protein accumulation by immunostaining (IHC). Results: We did not detected evidence of microsatellite instability for the particular microsatellite markers. Also, MSH2 and MLH1 proteins retained their nuclear expression, in all cases analyzed. About 20% of the cases seemed to be carriers a p53 aberration (7 in exon6, 2 in exon7, 2 in exon8 and 1 in exon5). The vast majority of mutations were documented in invasive ductal type – high grade tumors. In all (but one) cases that produced a variant DGGE-pattern, gene alterations were identified by sequencing. Of these, two mutations: a missense at g.13418T>A (p.Y220N) and a deletion at g.13270delG have not been previously reported in breast cancer. The presence of mutations revealed a strong correlation with high-grade breast carcinomas (p=0.002). Positive immunostaining of p53 protein was observed more frequently in invasive breast carcinomas (51%) than in in situ component (27%), with statistical significance (p=0.043). P53 overexpression was associated with the presence of mutations in p53 gene (p=0.004). Conclusions: Our findings, in agreement with other reports, indicate that genetic events involving microsatellite instability and MMR protein deficiency, which are crucial in colorectal and other tumors, are uncommon and do not play an important role in breast cancer. Due to the difficult comparison and evaluation of the results of different studies, further analyses on large series of breast specimens using more informative markers, should shed light on this issue. Regarding our results on p53, PCR-DGGE assay is an efficient and highly sensitive prescreening approach of p53 mutation detection in DNA samples of breast cancer patients. The combination of molecular techniques (DNA sequencing) and immunohistochemistry should be considered the “golden standard” for the detection of p53 abnormalities and confirm how a mutation could affect protein expression. The presence of mutations and p53 protein accumulation in invasive carcinomas, as well as the significant correlation between mutations and high tumor grade, reveal their possible implication in advanced stages of breast carcinogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zachariou, Christianna
- Ζαχαρίου, Χριστιάννα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17538